KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Total Non-Current Liabilities (2020 - 2025)

Oscar Health's Total Non-Current Liabilities history spans 6 years, with the latest figure at $5.3 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 40.66% year-over-year to $5.3 billion; the TTM value through Dec 2025 reached $5.3 billion, up 40.66%, while the annual FY2025 figure was $5.3 billion, 40.66% up from the prior year.
  • Total Non-Current Liabilities reached $5.3 billion in Q4 2025 per OSCR's latest filing, up from $4.7 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $5.3 billion in Q4 2025 to a low of $1.6 billion in Q3 2021.
  • Average Total Non-Current Liabilities over 5 years is $3.3 billion, with a median of $3.4 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 94.87% in 2022, then decreased 25.1% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.9 billion in 2021, then soared by 92.3% to $3.6 billion in 2022, then fell by 23.42% to $2.7 billion in 2023, then soared by 37.94% to $3.8 billion in 2024, then surged by 40.66% to $5.3 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Total Non-Current Liabilities are $5.3 billion (Q4 2025), $4.7 billion (Q3 2025), and $5.2 billion (Q2 2025).